In transgenic mice expressing the PD-associated A53T mutation in human α-synuclein, 3 months of mild continuous DSS treatment promoted a-Syn aggregation in both enteric neurons and the SN, increased the loss of dopaminergic neurons in the SN, and expedited the onset of motor behavioral abnormalities38. This evidence concerns the gene SNCA and Parkinson disease.